NewsBenzingaJP모건, 사바라 제약 투자의견 ‘비중확대’로 커버리지 개시···목표주가 12달러 제시 JP모건, 사바라 제약 투자의견 ‘비중확대’로 커버리지 개시···목표주가 12달러 제시 Benzinga 2026.10.07 16:32 (GMT+0) Open on Benzinga Other news Hewlett Packard Enterprise Stock Hits 52-Week Highs - Here's Why Citigroup Maintains Buy on Zscaler, Raises Price Target to $245 Citigroup Maintains Buy on ArriVent BioPharma, Lowers Price Target to $20 Spotify Takes Its Audiobook Push to More Than 180 Markets Citigroup Upgrades Flutter Entertainment to Buy, Lowers Price Target to $91 Lake Street Initiates Coverage On Fossil Group with Buy Rating, Announces Price Target of $10
